Assessment of Adult Hip Dysplasia and the Outcome of Surgical Treatment

Embed Size (px)

Citation preview

  • 8/18/2019 Assessment of Adult Hip Dysplasia and the Outcome of Surgical Treatment

    1/17

    DOCTOR OF MEDICAL SCIENCE DANISH MEDICAL JOURNAL

    DANISH MEDICAL JOURNAL  1

    T ee a bee acceed a a e gee ee e bed

    ae b Te Fac f Hea Scece, Aa Ue, Jaa 3, 2012 ad

    defeded Feba 24, 2012.

    Offca e:

    Pfe Se Oegaad, Odee & Pfe Ja E Made, O

    Ue eeeae: Acae fe, Bee L. Lagda, Aa

    Cedece: Deae f Oaedc, Hde Ha, Keegd A 30,

    2650 Hde, Dea

    Ea: [email protected]

    Da Med J 2012;59: (6)B4450

    Te dca e baed e fg ae, efeed

    e e b Ra ea (IVII):

    I. Tee A, Re L, Kg S, Eegaad B, Sbae K. Ae

    e f daa ad ea: Vaab f dffee

    ed. Aca Rad 2010;51:187193.

    II. Tee A, Jacbe S, Re L, Sbae K. Wegbeag

    aee ec adga ae eceded DDH

    aee. C O Rea Re 2008;466:813819.

    III. Tee A, Re L, Jacbe S, Laded S, Sbae K. Caa

    aceaba ee c DDH e egbeag

    . Aca O 2010;81(4):436441.

    IV. Tee A, Jacbe S, Bg L, Geec J, Re L, Sbae K.

    Uad e MR aga aceaba aba ea

    dagc. Aca Rad 2007;48:10041010.

    V. Tee A, Mecebg I, Geec J, Bg L, Jacbe S,

    Sbae K. Wa e e f cca e ad ad

    aceaba aba ea dagc? Aca O 2009;80:314318.

    VI. Tee A, Eegaad B, Sbae K. Mede ce

    f eaceaba e ad edc f ce a

    eacee. J Be J Sg A 2009;91:21692179.

    VII.Mecebg I, Negaad JR, Geec J, Sbae K, Tee A

    Caage ce e eaed b MRI ad ee

    g befe ad afe eaceaba e. C O Rea

    Re 2010;468:18841890.

    H daa ad defe geea ae ecged

    a be ec f eac deee. Ea ad

    cec defca f daa a de

    ffe e eeg eae. I e cea

    eae, eea cee e, ad e f ee ee e

    fc f dca e. Caeged bec, e a

    fdg ad e be ace ae ed be.

    A bee d afed e aab f dffee

    ed f dagc aee f daa ad

    ea ad eed geea eceda egadg

    dagc aee f daa. Pec a

    dffe gfca beee e e ad egbeag

    ae dac . T a fdg a

    add ce e aca f ea ec g

    dg aee f defe becae ec affec

    e aeaace f aceaba e. Wegbeag ae

    e f aceaba e ed e eece f ee

    33% f dac . Te eabe f ee a a

    ae fee e dac cadc e

    ca fdg a daa caaceed b ffce

    ae ad aea ceage. I geea, e fdg ae

    a ca f edc ge ad adg deag

    dagc aee f af g ad, ad

    f ge ag ad efg eeg e

    aceaba ee.

     

    Te e f ad ad cca e aceaba aba ea

    dagc ee eabed. Afe ecg a a eagce, ad ega a g eabe dagg

    aba ea, eea a e gee FABER e

    a eabe defg a aba ea. I ee a ae

    ad ad ad eaa efed b a eeeced

    eae ca ea ae e ada dagc ag

    c agec eace aga ea e gd

    adad.

    Ecagg a ad cca ce ee eed

    a ede f afe eaceaba e. Te

    a be f de eg e ce bed a 5ea

    f ca e de aca f e eaceaba e. Te efed aa f edc f

     

  • 8/18/2019 Assessment of Adult Hip Dysplasia and the Outcome of Surgical Treatment

    2/17

      DANISH MEDICAL BULLETIN  2

    ce a eacee fg eaceaba

    e dceed e ace f dffee beca

    ca ad degeeae fac. Kedge ab fac edcg

    ea ce a eacee a e ea

    efe ae eec ad e eae b eaceab

    a e. Caage ce a dceed be eeed 2 ea afe eaceaba e. A b 1

    ad aceaba aba ea, dcag a e

    eece f aba ea de acceeae caage degeea

    afe eaceaba e.

    .

    I 1939, Wbeg ed a e aadg f daa e

    eac (1). He caed ae daa a a be e

    c f eae eac deee. Ag e

    a cb aadg e af ce a

    fed ee Sbeg ad Ha, Cea e a., Haegaa

    e a., ad M e a., a egaed e gge f

    Wbeg e aca beee daa ad ea

    (26).

    Te deadg a ca def a cae

    ea a a e fc f e a eeac f

    e 1960. Ma, fed b S ad Ha, ggeed

    a ca defe f e a fe (.e.

    g defe) ee acaed eac dee

    e (712). Te deadg a a fea ad

    aceaba defe ge e dbed becac ad

    ea degeea a bee addeed b Ga ad ceage

    b dcg e cce f feaceaba gee

    (FAI) (1314).

    Cea eeac daa a fded b e

    dc f e eaceaba e (PAO) f e

    eae f ac daa ad b Ga adceage 1988 (15). Te eac deadg f e e

    f e aceaba ab ad f e agca becac

    caaceg e dac a aed b a dec

    f e aceaba de b Kae e a. a fe ea

    ae (35). Reeac eff ae bee gee, b e a

    20 ea ae cee ad aeed e e.

    Te a f e de eeed dca e ee

    ed b ee cee, aeed e, ad

    e e aed e cea eeac

    daa. Dagc aee ad eae f ca

    def ae a g adgac deadg a

    a . I e fc a bee e cea c

    ee f eab f adgac aee, a

    g f e ae f ec adga ad aee, adaceaba ee daa ad e e eaed

    e deedece f ee fac ec g (IIII). I

    accdace e ee ee ee aba ag

    f, e a f a f e eeac a bee acea e

    be e f ad ad cca eaa aceaba

    aba ea dagc (IVV). Baed a 20ea f f

    eaceaba ee, ee a e cede ca

    ccef eee eeced dac (73). Hee,

    fe daa ab e ed ad ge effcac f PAO ae

    bee fcg, ad edge ab edc f ce

    fg a gca cede ea ae. Tee

    bec ad e e f aceaba aba ea f e ce f

    eae f daa ae bee egaed dca

    e (VIVII).

    Fge 2.1.

    A ec f a aee ec adga g e

    g . H daa ee, ad e ceeedge age f

    Wbeg ≤20.

    .

    H daa caaceed b a ee ad a aceab

    ad ffce aceaba ceage f e fea ead (Fge

    2.1). Becae f e deceaed aea f aceaba ad feaead cac, ad fce e ceae. Aceaba c

    a cage fe aed da dg deee,

    ad ecee fea ec aee ad ag degee f

    ca aga ca e (3034,3840). T fe ccae e 3

    dea aaa f daa, a bee dc

    eed a ag degee f aceaba ee ce

    a a a 40% f e (4142).

    F decade a bee ecaed a def

    cd cae ea (212). Dg e a decade,

    edge f e agca aeed becac caed b

    defe ad c ead ea f e a

    g eea. Te becaca cce f FAI a bee

    dced, ad c acceed a eeaed

    c beee e aceaba ad e fea ead fea eadec c e cae eag f e ab

    ad bee deea (13,14,1728). H daa

    e f e defe fd be acaed FAI ad

    eac deee. Geea ab ad a ea

    g d f gee a cae eeaed, cc ead f

    e aceaba , be eag f e ab ad b

    ee dec f adace caage. I caca cae, e

    ac f ceage a a aeaea ca, ad e

    fee ca f aba ea dac (3537).

    Fe abaed eaece eae f def

    e cdg daa e (4547,52). Gg e a. ad

    Jacbe e a. e abaed eaece eae f daa b dg e Ceage Oea Sbd

  • 8/18/2019 Assessment of Adult Hip Dysplasia and the Outcome of Surgical Treatment

    3/17

      DANISH MEDICAL BULLETIN  3

    4151 cded dda (47,52). Sadaded egbea

    g aee (AP) ec adga ee baed, ad

    g a ceeedge (CE) age f ≤ 20 a adgac cff

    Gg e a. eed daa 4.3 % f ae ad 3.6 % f

    feae (52). Tee eaece f daa ae g

    a a e eed b ee (4546).Te edece a daa ca cae eac de

    ee g agca aeed becac eg

    aba eag a deed f cca bea

    a, g eeced c (16,3437,5658). I a d f 96

    ac dac , Jee e a. defed e e

    ece f a aceaba aba ea a a deede edc f

    baa ea (62). A fe abaed e

    ae f eac deee dac e.

    Rea e a. (60) ad Lae e a. (61) efed ece

    abaed c de. Lae e a. (61) caed

    ceaed (OR: 3.3) f cde ea ede (a >

    65 ea) e e d daa (CEage < 30). I

    e d daa a defed a a CE age

  • 8/18/2019 Assessment of Adult Hip Dysplasia and the Outcome of Surgical Treatment

    4/17

      DANISH MEDICAL BULLETIN  4

    We aeg cea AP ec adga f e

    eece f daa ad ea, a eae a aee f e c ed aaee a

    ee a ad ebee aab (7579, II). T a

    ca f e a ad abee eea f e

    dag f daa ad e degee f daa ad

    ea. Becae f ee aa, e dca

    f eeg ge a a.

    Tee e a. (I) cdced a bded, 4bee d

    eac bee efg 2 aee b ad 2 ae

    e b age cc 50 . A eae ee

    caed e ade CT ca. Te a ad e

    bee aab f age aee a e e age

    ee cced caed aee b . Ia

    bee aab a cfed aae 10 f

    aee b ad aae 5 7 faee b age cc. Iebee aee

    ed g ge aab, ad a a dffeece be

    ee aee b ad b age cc. Te

    bee ab dage daa ee geea

    ed e age ee cced caed aee

    b . Aee f ea geea ed

    ageee fdg CT ca, aee f a JSW

  • 8/18/2019 Assessment of Adult Hip Dysplasia and the Outcome of Surgical Treatment

    5/17

      DANISH MEDICAL BULLETIN  5

    Fge 3.1.

    A ec f a aee ec adga g b

    . Te e aead a e dace f e

    e accccgea .

    aceaba e (8286). Cea, e aca f eaec g eagf f ec affeced

    gfca b dffeg ae g e g

    ca age f (.e. eg f e egbea

    g ). Hee, e eae, ee a bee c

    e egadg e effec f cage f f e

    egbeag ec (8793). Tada, AP ec ad

    ga ae bee ecded ae e e .

    Tee e a. aeed AP adgac dce f da

    a, ec , ad aceaba e 31 e f e ad

    egbeag ec adga (II). Sa ea edc

    e CE age (1.3 1.6) ad a ea ceae e AI age

    (1.6 2.3) ee beed e eg f e e

    e egbeag . Hee, e cage age

    eae ee caed e ee abeeaab (III). FcWea e a. (94) aeed 61 e f

    e ad egbeag adga, ad eed a aga

    bgge, gfca edc e CE age (3.6) e e

    g a dd Tee e a. Ia ad ebee aab

    eae ee, ee, eeed b Pea cea

    ceffce, eag b ae e aca agde

    f e aab. FcWea e a. beed a gfca

    ea edc JSW f 0.49 afe eg (94). Te

    e e a. beed a gfca edc ae ef f 0.67

    eg (II). S, e eae b de

    cfed e beed abee aab f e JSW

    (II). Oea ad feae, Tee e a. dd bee gf

    ca cage eg, ad ed b fdg

    e de (95,96, II). Tee e a. dd fd a eeafea ead aa afe eg f e e

    e egbeag (II).

    Seea de ae eaaed e effec f eg (.e.

    f e egbeag) cage ec (Tabe

    3.2). Ug ag ed f aee f cage ec

    , e de e gfca cage (87,90,92) ad

    e a gfca ee (bacad a eca)

    f e e f aae 4 8 (88,89,91,93). T

    e a ec b ae ecee dg e

    g, Naa e a. ad Babc e a. fd a ec dd

    eceed a cage f 10 90% ad 83% f e cae, eec

    e (87,90,93). Ug a dec eae f cage ec

    , Tee e a. eed a gfca cage ec f

    13 14 feae ad 6 7 ae afe eg (II).

    A deae g cea beee e dace f e

    e accccgea (ed b Tee e a. (II))

    ad e degee f ec a bee eed (97) (Fge 3.1).

    Oea, e de agee a a ee f e e ae

    ace eg (8793, II). Ca f de

    be becae a de ae f ed ae ed ad d

    a b a ad ed eegee (Tabe

    3.2). I ee, ee, a d a a b ec daa ae acaed e e f gfca

    cage f ec dg eg (88,89,91,93, II). A

    ea ae daa, e fe geeaed ab

    ad ceage defcec cd cbe ceaed ec

    ba dg eg.

    I cea a e ae degg, b dee ce,

    ee ae de e e a ee ae

    gfca eeded e eed f e eg

    beag (88,89,91,93, II). I e g f , e aca f

    adaded, caed ea ec g (.e. ag

    dffeece ec beee e ad egbeag

    ) cea (82). T fe afed b Te

    e e a. eed a 32% f ae e eg

    beag ee cfed e f ea ecg ggeed b Sebec e a. (82, II). A e

    f e ae a fd affec e aeaace f

    aceaba e becae 11 ae ed g f ee

    e e e 4 ae e egbeag

    (II). T eaed b e ee f e e

    cec eg.

    I a, ec adga f aee f de

    fe ae a ecded e ae e, ad e

    a ec g a bee adcaed (82). Hee, baed

    e ee eae, a gfca ec ee a ae

    ace afe eg f e e e egbeag

    (88,89,91,93, II). Fe, a gag f e

    ac ca defe fe aeaed ee

    dg fc. I g a egbeag adga

    ece e be ceece beee , fca a

  • 8/18/2019 Assessment of Adult Hip Dysplasia and the Outcome of Surgical Treatment

    6/17

      DANISH MEDICAL BULLETIN  6

    eaace, ad defe. Fa, AP adgac dce f

    daa, fea ead aa, ad e JSW

    dffeece beee e e ad egbeag

    (94, II). Tee e a. eced egbeag AP ec

    adga f aee f defe (II).

    Aceaba ee a bee ecged a a be ec

    f eac deee ad a a ce f a

    (43,44,86,98). Te e a bee fd be acaed

    e eece f aba ea, ad caed e b

    ecaca cce f FAI a a fca eceage cag ce

    gee (14,56,57). Te f aee f aceaba e

    e ade a AP ec adga b defca f

    a cg f e ae ad e aceaba . Red

    e a. decbed caed ce g aae a

    decade ag (98) (Fge 3.2). Jaa e a. fd e ce g

    be g ad aee f aceaba ee AP

    ec adga (99). Sebec e a. eed a aceaba

    ee ge e ced ceag ec fe(ca fad a) (82).

    Hca, daa a bee decbed a a cd

    acaed aea ad ae aceaba defcec ad

    aceaba aee (30,31,33,34,37,100). I eefe

    ea g a dg e a 5 10 ea, eeca

    e a 2 ea, aceaba ee a bee eed

    ce daa a cdeabe f dac

    (41,42,8386,101,102, III). Te eed eaece f

    aceaba ee dac age f 15% 42%

    (Tabe 3.3). Te cg f aceaba fee

    ee e caa d f e dac aceab (86,101, III).

    Te degee f daa, afed b e CE age, de

    ee dffe beee eeed aceab ad a

    eed aceab (42,84,86, III).

    A aead ed (ee ec 3.2), cea

    ee defe d be aeed AP ec ad

    ga e e ea ed e egbea

    g . Te aeaace f aceaba e ad ee

    deed e degee f ec , ad e eaece

    eae f aceaba ee deed e ad

    gac ed aed (82, II, III). M de eg e

    eaece f aceaba ee dac cde

    adga f e ee cea adaded cea

    eec ec (Tabe 3.3). I g f e beeed dffeece

    ec afe eg ad e ceece beee de

    fe ad fca aeaace e eg beag

    , Tee e a. aeed e eaece f ee

    egbeag AP ec adga (III). Tee e a. fd

    aceaba ee 33% f dac , c ge

    a e eae f aae 15% 20% eed e

    a f de (8386,101, III). T dffeece eaed b

    e ec f ee ecee fe (ca

    fad a). Ta , e ee ae ecde a b

    ae ae ecee feed ad eefe ae e ae a

    e ced aeaace f ee. I geea, de

    e a afg gd a ad e bee aab

    e aee f e ce g (99,103,104, III). Aee

    f e aceaba ad e ce g dead gd

    a adga. A a aeae, e ca e g a

    bee dced a a ad dca f aceaba ee

    (103).

    Te cca ace f aceaba ee d

    aa ad ca f eface f a edece PAO

    Fge 3.2.

    A ec f a aee ec adga g e ef

    . Te daed e a e ae aceaba ad e

    d e e e aceaba . A ce g e

    e a e daed ad d e eec.

    ae e f ded. Rece, daa aceab

    a ee a fd be acaed a eae e

    f a (86). A, ece de ae eed e ace f

    ecgg aceaba ee dg eeae ag

    ad eface f edece PAO (84,85,102). Fae d

    e ced ee aggaaed ee a

    deceaed age f ad a eae FAI c

    ed deea. Aceaba ee a bee e

  • 8/18/2019 Assessment of Adult Hip Dysplasia and the Outcome of Surgical Treatment

    7/17

      DANISH MEDICAL BULLETIN  7

    ed e 10% 62% f dac fg ed

    ece cede. (84,85,102).

    I a, e defca f aceaba ee

    dac ea a a cca ad gca

    ca a eed fe ega. Reeed

    aceab ae g fee dac (15%42%)(41,42,8386,101,102, III). Becae e aeaace f aceaba

    ee deed e ec (82, II, III), e f

    e ae dg adgac ecdg a ea

    a fac a eed fe ea.

    .

    Dg e a decade, e deadg f e ea

    beee defe ad eac deee a

    ceaed gfca. Teag f e aceaba ab e

    adace caage ecged a e e deea

    a cae f becaca dced ea (14). Te de

    c f aceaba aba ea acaed daa

    e, b e aca becaca ee f e aceab

    a ab ad e a f degeea ae

    bee dceed (16,3537,107110). Te ab e

    ed ae a adag e, a ea daa, ad

    ac a a ea g e ee f bca

    (108,111). Fee, e ab a a abg fc a

    ec aga cca becaca aea e

    (112).

    Te becaca cage dced b e e def

    e daa, gee e ab f e , ae

    g ae e aceaba ab cebe ead

    ad eag. Tee eeca ad cca edece a aeag d f gee, eeaed c aa

    e ab, bee degeea, ad fa a ea de

    ace f e ab e cdaba a e,

    dee e becaca cce (16,3537,113,114).

    Aceaba aba ea daa ae fee fd

    e ae eg f e aceab, c a be eaed

    b e deadg becac, ceaed ad ad a

    eae ecaca ce f e ab aca

    eg (109,110,115,116, IV,V). Ae caacec feae f

    e ab fe ec ae dac

    (35,115).

    Teag f e aceaba ab a fee fdg

    ac dac . I 170 daa, McCa

    ad Lee fd a aba ea ac 72% (113).Sde g agec eace aga (MRA) ea

    ae e ab ac dac fd aba

    eag aae 80% (115, IV). Te fdg gge a

      ead ad aba eag a a a e e

    deee ae daa. Caca

    f daa ae a g a ad ccg

    cg f e , a f c ced e a aba ea

    ad c ead.

    Te defca f a aceaba aba ea a a cae f a

    ad a ec f degeea a fced ae

    eabe dagc aee. MRA a bee eabed ae adgac gd adad ed f e dagc ae

    e f aceaba aba ea (Fge 4.1). Rece de ae

    eed a gd ab f MRA dage aba ea (117119).

    Taa e a. efed MRA 30 ad fd a e

    f 92% ad ecfc f 100% e MRA fdg ee c

    aed e baed dg ac (117). Ca e

    a. eed a e f 100% ad a accac f 94% ( 18 degg bee ac) (118). Feeda e

    a. eed a 22 (96%) f 23 aba ea daged

    ac ad bee fd MRA age (119). Zege e a.

    fd a deec ae f aba ea f 97.2% MRA 144

    e ea a ac (120). Ce e a. bed

    e f e f d 1996 (=22 MRA) ad fd a

    e f 90% ad a accac f 91% f MRA caed

    acc fdg (121). I a ae d, Ce e a. ed

    a MRA ca be ed cec age aba ea (122);

    ee, e agg ee f e gc ae (119). Te

    aeade eab f MRA eadg a bee eed be

    ecee (119,121, IV, V). I ca ee ecagg e

    , Keee e a. (=104 ) ad Leg e a. (=23 )

    eed ee ad ecfce f aae 40% 70% f MRA aba ea deec (123,124). I d be ac

    edged a e de eg e dagc ab f

    MRA fe ffe edgca be, c a, a eec

    e deg, ac f a cea ece c f age

    eadg; ba dced b ac f bdg f adg e

    acc fdg; eecdced ba becae a a

    ae bee cded e eece d de e fdg

    f a aba ea ac; ad ebee aa

    becae eea adg acc ge ad a

    eed e eece f e aba ea.

    I e eae MRA, a bee eabed a e ad

    gac gd adad aba ea dagc. Hee, e

    ed ecg ad cfabe f e ae.

    Uad de ed ceea dagc adg,

    ad a bee eed a a ae e ab dag

    e aceaba aba ea eab (IV, V) (Fge 4.2). Fe d

    e ae egaed e ab f ad eaa.

    Mce e a. eed e e f 8 ad eaa

    a ad acc aee f ag: 1

    f 8 eaa ad daged e ag ee.

    Ge e edgca fa f d, cc ca

    be da, ad e a ae e f ad

    e ggeed dagc aac a (125). Sfa e a.

    eed a bece ee aa f aba a

    g b ad dg aaca ed ec

    21 . Magec eace agg (MRI) ca

    a efed 14 f e 21 , ad ee, ae aba

    ea ee fd 13 b MRI ad ad eaa

    . Te a dd af e dagc ab f a

    d. Te d g eee a f e ea cce

    f ad dage aba ag, b a cc

    ae ade ad b e eece deg a ea ee f

    cae a e fdg f aba ag dg a

    d eaa (126). A ece ca f ad

    MRA aba ea dagc a efed b Tee e

    a. (IV). Eaa ee efed 20 cece da

    c eeg a. Te ece c

    cded edefed cea f dec f aba ea ad

    bdg f e MRA adg ad e ad adg

    e fdg f e e eae. Te cedg fdg

    ad ad MRA ae eeed Tabe 4.1. Te eg

    e a 44% ad e ecfc a 75%. I a bee

  • 8/18/2019 Assessment of Adult Hip Dysplasia and the Outcome of Surgical Treatment

    8/17

      DANISH MEDICAL BULLETIN  8

    Fge 4.1.

    Ca e f MR aga ag a aceaba

    aba ea (a). Ca ed ee g g e

    bae f e ab.

    Fge 4.2.

    Uad eaa ae a aceaba aba ea. Tee

    a ecc cef g g e bae f e ab

    (c a), ad a cc fa be e e

    ab ( a). Te ce a e f e ab.

    d b Tee e a. (V), e a eaed e ab f

    ad deec aba ea, ag a c f e

    eface f eaa a e e ed e e

    d b Tee e a. (IV). Te f 18 ae

    e ad ad eaceaba ee ee ea

    ed. Te fdg MRA ad ad ae eeed Tabe

    4.2. T, e e f ad aba ea dagc

    a 94%. Te de (IV, V) ee egeed b e ec

    e c ed f e eface f e eaa, b

    ed b e eae a e f e d c, ad b

    e fac a e adgac fdg ee efed b

    ac. Hee, MRA e eabed a e ad

    gac gd adad aceaba aba ea dagc,

    a ecee cea acc fdg ece de

  • 8/18/2019 Assessment of Adult Hip Dysplasia and the Outcome of Surgical Treatment

    9/17

      DANISH MEDICAL BULLETIN  9

    (117119). Te a ad ebee aab f ad

    aba ea dagc ea egaed.

    A g ae ad a cca eaa d

    be abe ae c f a aba ea a e cae f a.

    B eabe ae c ed cca e e ae

    e f aceaba aba ea? Edece fed ed.Naa e a. (51) cdced a d eag 18 b a

    ea a, fe, aa ce e ad g MRA

    a dagc efeece. Te e a 75% ad e ecfc

    a 43%. I a d b Ma e a. (127) 6 edc

    ge, ecag a, efed cca eaa

    8 ae. Te cca eaa ee efed a efeed

    b eac eca. Baed e cca eaa, e

    edc ge ageed 63% f e e e fdg f a aba

    ea e fg ac. Tee e a. (V) e

    gaed e ab f e gee e, e FABER e, ad e

    eed ag eg ae e dage aba ea. Te cca

    fdg 18 ee caed MRA fdg f aba ea,

    ad e dagc ab f e e a cacaed (Tabe 4.3).

    Of e cca e, e gee e ed e be dagc ab, a e f 59% ad a ecfc f 100%.

    Ma ad Sea egaed e eae eab f e

    gee e ad e FABER e ad fd a deae

    ageee beee bee (aa: 0.58) f e gee

    e ad a baa ageee beee bee (aa:

    0.63) f e FABER e (128). Te fe de egag e

    dagc ab f cca e ae geea ed b a

    d a (51,127, V). Fee, e d b Tee

    e a. (V) ed b e fee eece f a aba ea e

    eeced d a. Te dagc ab f e ge

    e e ae a a ab dffc

    ae. Te ece c f eaa ad bdg f

    b e cca, ad, ad MRA eae eac e

    fdg a edgca eg, ad e d bea

    d a ae eeg a ae cc deag

    ecfca be ae g eeced.

    I cc, MRA a bee eabed a e dagc

    gd adad aceaba aba ea dagc. Te e f

    de e dagc ab f MRA ae bee cfcg. I

    e ece bed de, ee, MRA a bee

    eed ae ecee dagc ee (117119). Ua

    d a e ad g aba ea dagc. Te

    ee e dagc ab f ad deaed

    b a ca f e e f e de b Tee e

    a. (IV, V) gge a a eag ce acaed e e

    f ad aba ea dagc. Ee e ad f a

    eeeced ad eae, a e de b Tee e

    a., e f ceag a aa ad eea f

    fdg eeeed edgca dffce a ad be

    ece dg e f d (IV). Cca eaa de

    ec aba ea e eeda f e edc

    ge, ad ee e de ed e (gee ad

    FABER e) ae e eabe aba ea dagc

    (51,127, V). T e eae e eed f eabe ad

    gac aee. Te edge bae egadg e e f

    ad ad cca e aceaba aba ea dagc

    ed, ad e e f e e eeced c ea

    egaed.

    Pae eeg eaed a, eeca a g

    a, ad e a f ccg cg f e

    Fge 4.3.

    Sggeed aeg f dagc aee f aceaba aba

    ea ().

    d be eced ae a ea f e aceaba ab

    (Fge 4.3) (129,130). A egbeag AP ec adga ad

    a aea e f e ae eed dage ceg

    defe ad/ ea (129,130, II, III).

    T fe ae e c f a aba ea ee e

    eced ae, a gee e ad ea e FABER e

    d be caed , becae e e f ee e ed

    b e eae (51,127,128, V). B e ae bee eed

    ae a e edce ae f 100%, eag a

    edc f a g a, e ae e e ae

    a aba ea (V). Pe de ae eed ≥95% f

    gee e be e ae gca efed

    aba ea (19,49,50). O e e ad, a aba ea ae

    daged b e gee FABER e (ee f

    59% 75% ad 41%, eece), ad a egae ce f

    e e eabe (51, V). I cae, fe adgac

    aee aaed.

    If a eeeced ad eae ee dee

    e f aba ea dagc aaabe, a

    d eaa ca be efed ae a ea ea f

    e ab (IV, V). I e ad f a eae a e

    ce e eag ce egadg e eea f e e

    aa, e ed ee (94%) dagg aceab

    a aba ea (V). A fdg f aba eag ad ae

    e e a e ae aca a a ea (e edc

    e ae: 94% (V)). Te ee eae cce egad

    g e eab f fdg a aba ea ad ad ee

    fe d be cdeed eabe a. (IV, V).

    Fe adgac aee e aaed.

    MRA e eabed gd adad adgac ae

    e f aba ea. Te a be eaed cca e

    ad ad e ac f eab f fdg ae egae (51,

    IV,V). T, MRA d be efed ae f g a

    dced b e gee FABER e ad a aba ea

    ca be aed ad eaa, ad e aece ae ecfc eaed a (V). I e ece

    eeece MRA, e dagc ab a bee eed

    be ecee, e, ecfc, ad accac eae

    e age f 92% 100% (117119). Hee, fae dag

    e a aba ea ca be ed , ad ced

    c, ac d be efed.

    .

    Sce dc e a 20 ea ag, PAO a bee

    aded a e efeed cea eeg gcaeae f ac daa ad (15,72

  • 8/18/2019 Assessment of Adult Hip Dysplasia and the Outcome of Surgical Treatment

    10/17

      DANISH MEDICAL BULLETIN  10

    Fge 5.1.

    A eae aee ec adga g b

    . Te g a bee eaed a edece

    eeg eaceaba e. A ceeedge age fWbeg f 35 a bee aceed. H daa ed e ef

    .

    74,102,131147). Te cca a ae eee a,

    e fc ad ea eaed a f fe, ad ee

    eac deee eceag ce THR. Te

    gca a a 3dea eea f e aceab

    a e fea ead ceage, deceae ad

    fce, ad eee e ead f e aceaba ab ad

    adace caage ad f e (15,72,148150) (Fge 5.1).

    Weea e de decbe e e ce

    fg PAO (132144), a fe de e e ce

    a ed ad ge f (.e. e a a

    f f 5 ea) (7274,131, VI). T ac f de ege ce a ed ad ge f dee c

    aed b e de acceace ad dde aca f

    a gca cede. I e de egag e e

    d ad ge ce fg PAO, e a ed

    dcag fae ce THR (7274,131, VI).

    Tee e a. eed e ede cca ad ad

    gac ce 116 eaceaba ee 5.2 9.2

    ea eae. Seeee ee ceed THR,

    ad e KaaMee a ae ce

    THR a ed a 90.5% (95% CI: 83.594.6) a 5 ea, ad

    81.6% (95% CI: 69.789.3) a 9.2 ea [VI]. Oe a e

    g e ed ge ae

    caabe ee be (7274) (Tabe 5.1). Fe, a

    ed Tabe 5.1, e d g ae g caabe.Se a ae (.e. e a a f

    f 5 ea) ae fee eed be >90% (132

    144).

    Te eee f f PAO ae b Tee e a.

    ced a ee, a cca eaa, a adgac

    eaa (egbeag aee ec adga),

    ad S F (SF)36 (151) ad Wee Oa ad McMae

    Uee Oea Ide (WOMAC) (152) eae

    (VI). Te e f e f eaa ae eeed

    Tabe 5.2. Ke feae f e ee ad cca eaa

    ee a f: Meda a ce e a aag cae

    ee 0 a e ad 1 afe 15 e f a ag. Te

    g a e fee ca f eaed a d

    cf. Ccg cg f e a ee 25% f  , ad a e gee e a fd 18%. H

      ea ad be ceg aaca be

    a ea ee fdg. Seace e a. ed e ge

    e e a e 24% f a 10ea eaa

    f ae degg PAO ge (73). Tee e a. eed

    age f a eda fe f 100 a

    e 10ea f e fd b Seace e a. (73, VI).

    Rea f ce a efed 18% f e eaed a

    e e f ede f, ag a ae f

    ace dg e a eeae ae fa e(VI). Tee e a. ed e cecc g e b

     ec f PAO ge becae 19% ad cage b afe

    ge de be (VI).

    Te Ha H Sce e Mee dAbg & Pe Sce

    ae bee e efeed ecfc fca ce e

    de eg e ce f PAO ge

    (72,73,102,132,133,135137). I dbf ee ee ce

    de a afg aee eeg PAO ge

    g ad. Tee e a. aeed e ce a ed

    e f afe PAO ge g e cea SF36

    ad WOMAC ce (Tabe 5.2) (VI). Ca e fe e

    de g e SF36 ad WOMAC ce ced b

    dffee da f f ad dffeg aege f daa

    afa (72,144,145). Ca f e SF36 ceeed a ede f b Tee e a.

    ae daa f Da ce f a eea age g ed,

    g, a e ca ce ce a e

    e ae ad a e ea ce ce ee

    caabe. (151, VI). T, ee a ea ea

    egae feced b e deea ca ea

    ae afe PAO ge a ede f. I add

    , e eda a WOMAC ce f 84.4 fd a ed

    e f afac. Of de eg e ce

    f PAO ge a ed ge f, e de b

    Ka e a. (72) (g e WOMAC ce) ad Seace e a.

    (73) (g e Mee dAbg & Pe Sce) e b e

    ad eae ce, eea e de b Maee e a.

    (74) (g e WOMAC a bcae) ad Tee e a. (VI) aeed b eg e eae f ce.

    Fa, a ecfc aeeaed ce eae eca

    cced f g ae degg eeg

    ge, c a e PAO, ea be deeed.

    Ee g de acceed, e e f ce THR a

    a ed e a beac. A e e f f

    , e ae a ae deeed edage

    ea fca cg a. Te

    a a af f a THR e ea fe, ad e e

    fae ae a be deeaed. Tee c ac

    ceed def f c ecda ed cde.

    Maee e a. cdeed a ce f ≥10 (f 20) e WOMAC

    a bcae a e e f f be a cca fae.

    Cee, a adda 12% (16 f 135) f e d g

  • 8/18/2019 Assessment of Adult Hip Dysplasia and the Outcome of Surgical Treatment

    11/17

      DANISH MEDICAL BULLETIN  11

    afed a cca fae (74). Ka e a. eed a 8 (31%)

    f 26

    ad edage ea (T gade 3) a deea f

    e WOMAC a ce f >20 ed ge f

    afe PAO. T g a eaaed f e g f ae

    a aae afg cca ce ad ae

    ad ad a THR (72). Seace e a. e ce e

    ae c a e d b Sebec e a. (131) ad fd

    a edage ea (T gade 3) ad deeed 5

    (7%) f 68 . T ee gaded a ag a e

    accdg e Mee dAbg & Pe Sce a a f,

    b ee e a ad edage ea cea

    (73). Tee e a. fd a edage ea (T

    gade 3) ad deeed 6 (6%) f 93 (VI). Pae

    f ce ae be eaed e e f c

    e THR a a ed . H a f ee ae ae

    ad e PAO ceed a THR a ae ? I e

    d b Maee e a. 23 (15%) f e a 158 egbe d

    ac ee f, ace f e be

    d e f ea afe ge (74). Ka e a. ac f 20

    (36%) f 55 cece ae dg e f. Te a

    ecded 9 f 35 ede, f c 2 ad a THR efed

    (72). Seace e a. ac f 5 (7%) f 75 . Hee, 3

    f ee ee ee a f 10 12 ea eae

    ad ed gd ecee cca e ad ce

    THR (73). I e d b Tee e a. 12 (10%) f 116

      ee f (VI). Hee, d bea e

    adaage a e Da H Aa Rege

    (63,153) a ade egadg ce THR a 116  , g e ceee f e f. Ne

    f e f ad ad a THR.

    Pae f, e acced f b a

    aa aa ege, add cea e e

    ed a ae, ad eaag a cca ad/

    adgac ed e a ce THR a add

    gfca e fae ae. Ied dffeece cceg

    ee e ca ea ea ee gfca dffeece e

    eed ae. Te ac f ce egadg e

    e f ce beac, ad ae a f, a

    ae ad ffce a f de eg e ce

    fg PAO ge, e fg cea ae ggeed: 1)

    Ce THR d be eed. 2) Deee f ed

    age ea ad/ a ce f ≥10 (f 20) e WOMACa bcae d be eed. 3) I aa a

    a ege, f be, egadg ee deeced c

    e THR d be ade. Oee, e a 10%

    15% d be f. 4) F d be e

    fed g cea WOMAC ad/ SF36 e

    ae.

    Te edgca eaee f e de eg e

    d ge ce fg PAO ge ca geea

    be abed e eece deg (7274,131, VI). F

    e, e e cea adga dage e e

    ece ad degee f ea, ad eefe fca geea

    ed caage deea a g deeced. Fe de

    eg e ce f PAO ge d f a c

    ece c, g cea cg e, ad

    agec eace agg caf e aaca c

    f e . Fa, e cc, e g age

    a e ge ad eeace e fed f PAO edc

    ae fge ef a aded d a d dee

    e ee ae ba ffce beef b degg a

    PAO caed , f eae, ceae eae. O e

    e ad, adg g ae ceac da

    a, ea, ad adag a ceae ea

    e THR d ee eca e de ae a

    PAO ge eee f 2 decade ad ed

    gd cca e eeced ae (7274,131, VI).

    Iceaed edge egadg ae eec cea ad

    fe fc aec f aceaba eea ae e

    facae fe ee e ce f PAO ge.

    Ug a dece ad caae aca aace,

    e de ae ggeed a adaced eeae

    ea (T gade 2 3) a a edc f

    fae ad ce THR (72,131133,154). Fe

    de ae dced aca eae. Seace e a.

    fd a aca gfca aad a f 3.39 e T

    gade ge (73). M e a. eed a aca gfca

    aad a f 2.19 f a eeae T gade f 2

    (142). Tee e a. fd a aca gfca aad a

    f 5.54 f eeae T ea gade 2 3 ee

    ee (VI). I add e de g cea adg

    a dage e T gade f ea, Cga

  • 8/18/2019 Assessment of Adult Hip Dysplasia and the Outcome of Surgical Treatment

    12/17

      DANISH MEDICAL BULLETIN  12

    e a. fd e dGEMRIC (deaed gadeaced ag

    ec eace agg f caage) de, ed a a ea

    eae

    f ea, be e a edc f fae f

    PAO ge (143). A ceffecee d e abe

    fdg cca de becae a THR a be

    e ceffece a PAO T gade 3 ea,

    ad T gade 2 ea; ee, PAO dd becae

    e ceffece f ae ed e a aae

    18 ea (155). Ve fe deae adaced

    ea ca be eeced a e a 18 ea (73).

    I e aa f edc f ce THR fg

    PAO ge, Tee e a. eee aaed degac

    ad adgac (cea ad ced gac (CT))

    e ad eae aaee (1,35,68,156,157, II, VI). Ug

    e C a aad de ad adg f e e

    eae gade f ea, e fg 7 aca gf

    ca edc (1 5 aeed cea adga, 6

    7 eeae CTca) ee defed: 1) a eeae CE

    age f

  • 8/18/2019 Assessment of Adult Hip Dysplasia and the Outcome of Surgical Treatment

    13/17

      DANISH MEDICAL BULLETIN  13

    aaed e aadg f cca de eaag PAO

    ge, ad e ffe gdace f fe, age de.

    I cc, PAO ge d a be efed

    g g f ea (T

    gade 01). Pefg a PAO adaced

    ea d be eced eca dca, c ag age f e ae. I add, e eecg ae f

    PAO ge, eca fc d be fac egae f

    ecg e becaca ee b ead ea

    e.

     

    Te e f aceaba aba ea e aagee f

    daa ea a dced ad cea e PAO

    ge. I geea acceed a defe f e ,

    cdg daa, ca cae FAI eeaed aa e

    aceaba ab, bee aba eag, ad caage de

    geea (13,14,1728,3537,107110,113,114). Sde ae

    defed e eece f aba eag 80% f ac dac , dcag a aba eag a

    a fac e deee f a ad e f

    deea daa (115, IV).

    Te eface f a adde aba ea dg

    PAO ge ce decbed e eae. A

    e eeae gee e a bee ggeed b Se

    ace e a. a a gfca edc f fae fg PAO

    ge (73). Te eed a e eece f a eea

    e aba ea e ea f e eed g ad

    fe ggeed a efg PAO adda a

    ad aaca ee a e ce (73).

    Hee, dag cc baed ce f e

    gee e , a e ed, dbf (V). Pee e

    a. eed e ce f PAO 83 , a ea f

    f 46 , ad 11 aba ea, e e

    ed a aeage Ha H ce f 90 ad g gee

    ea a e ece f (102). Fe,

    Maee e a. ee abe fd a e eece f a aba

    ea edced fae f e PAO e aae ege

    aa (74). Te a ae eed de

    c e ad ab ee ef ced ae ecagg

    (140,141, VI). Acc eae f aba eag

    addeg e daa b ea f a PAO cea.

    Teae a cae a adee ce (acceeaed

    ea), ad e bed e f ae

    (158).

    Mecebg e a. (VII) eaed caage ce e

    26 ae b g agec eace agg ad

    aca f a eegc ed (159) befe ad 2

    ea afe PAO ge. Tac a aed e eg deg

    g agec eace agg eaae aceaba f

    fea caage. I add, 18 ae dee MRA f e

    eaed dage aceaba aba ea. I a fd

    a eeae aceaba ad fea caage cee

    ee a eaee 2 ea afe ge. A ea

    ee 1 ea eae, e aceaba caage a

    gfca, ee aga, ce a a 2 ea

    eae (1.47 . 1.35 ). Seeee f 18 ae

    degg MRA ad a aceaba aba ea.

    Se edgca a d be acedged

    (VII). Te eg ac aac ed dg agec eace

    agg a ae ed a deea f ea caage

    ce de dffc eaag caage e ce

    cea a f e . De e ada f eae

    e ed eegca ed, a ca aea

    g e e a g deeced, a aga

    effec ea caage ce. T a be a be

    cae deea a a be caaceed b ca

    caage daage adace a aba ea. Tee a ef e ad eae fca ce eae dc

    e e cca effec f e PAO efed f e cea

    f ce e fdg f caage ce ad

    aba ea. Hee, e e f e ad eae a

    aag cae a ce dceed e a eef f a.

    Magec eace agae ee efed e

    eae ad eefe ca be dceed ee aba

    ea ee ee eeae. Hee, ea f e ab

    ae bee dceed 80% f dac (115,

    IV).

    If e acedge a a ca aea caage

    daage a g deeced, aea a caage ce

    eeed 2 ea fg PAO ge. Ne f e

    e d ad a a ad aba ee dgPAO ge, ad g a 17 f 18 agae deeced

    a aba ea, ee a dg e f e e

    ece f a aba ea de acceeae caage dec.

    I cc, de f ffce edgca ae

    ae e aaabe defe caf ee a ad

    aba ee d be efed . Accdg

    eg de, b aace ca be ce. Te edb

    ad deceae ad fce gee e eg eef

    f ead e aceaba g be caed b e

    PAO (15,54,72,148150) a ea a eeed def

    ace f e eece f a aba ea ad caage dec

    eeg eeed. Fe ece de

    g eeae agec eacebaed dagc f

    aba eag ad ca f cca ad adgac

    ce ae aaed.

    .

    Aaee f e a ad cee f dagc

    aee f defe ad ea ae

    a becae cec dag a gea ca f cad

    dae f eeg ge. A eee afca f

    e aab f dffee ed f e aee f

    daa ad ea a caed (I). Te gge

    ade egadg aee f daa ae ca f

    a edc ge ad adg deag af

    g ad. Edece a ge a ae daa, ec a dffe beee e e ad eg

    beag (II). Sed b e de (88,89,91,93),

    fdg e e e f adaded ea ec

    g dg aee f defe becae e AP

    adgac aeaace f aceaba e affeced b e

    degee f ec . I a eaa f aceaba e

    dac egbeag AP ec adga,

    aceaba ee a ee 33% f (III). Aaee

    f e be ace f ae g ad f e fe

    e fdg f aceaba ee dac

    aca a dg aee f daa ad e

    ag ad eface f a eeg PAO. Lage cae

    de ecdg b aea ad AP ec adga f b

    a ced ad defe ae eeded ed fe g e ace f ae g.

  • 8/18/2019 Assessment of Adult Hip Dysplasia and the Outcome of Surgical Treatment

    14/17

      DANISH MEDICAL BULLETIN  14

    Teag f e aceaba ab a bee defed a a e

    feae e a f ea eac deee

    ca defe (13,14,1728,3537,107

    110,113,114). Te e f ad ad a cca e

    dage aceaba aba ea a eabed (IV, V). Afe

    ecg a a eag ce, ad a ed be g eabe dagg aba ea, eea a

    e fdg e gee FABER e a eabe

    defg a aba ea. Ve e a e ab

    e ab f ee dae dage aba ea. I ee

    a ae ad ad ad eaa efed b

    e eeeced eae ca ea ae e ada

    dagc ag c MRA ea e gd adad.

    Hee, fe ega ae eeded ee e f

    ea f ad. A eeeced b edc ge

    f ad e d, cca eaa ea eabe

    dagg aba ea, ee e ad f eca (127).

    Becae a a ee e, eea ad

    gac eaa eeded.

    I e e fe e de (7274,131) eg eed ad ge f e afe PAO f e

    eae f daa, ecagg a ad

    cca ce ee eed (VI). Te a be f

    e e ce bed 5ea f caed b

    e de aca f e PAO. Sge ad ae ae aa

    g fe cda f e fa ecagg

    eeg abe f PAO, ad a aec, eeca e

    eceed b e ae be a, ae degg e

    ga ea egaed. Te a d be e ef

    ace f ece f de. Te efed aa

    f edc f ce THR afe PAO dceed e

    ace f a becaca ad degeeae fac

    (VI). Kedge ab fac edcg ea ce THR

    a e ea efe ae eec ad e e

    ea f PAO. Te e dcea f c fac,

    bed e egae fece f eeg ea

    , a e ed. Caage ce a dceed be

    eeed 2 ea afe PAO (VII). A b e ad

    aceaba aba ea, dcag a e eece f aba

    ea de acceeae caage degeea afe PAO. H

    ee, e e f aba ee dg PAO ea g

    cea. Becae fa cc ca be da f

    e ee ffce edge bae, a ece, MRA

    baed, f d aeg ce f PAO beg c

    dced.

    1  Wbeg G. Sde dac aceaba ad cgea ba f

    e . W eca efeece e cca f ea.

    Aca C Scad 1939;83( 58):5135.

    2  Sbeg, S. D. Aceaba daa ad deee f ea

    f . Ha, W. H. Te . Pceedg f e ecd e cefc

    eeg f e ce. 8293. 1974. S.L, C.V.Mb.

    3  Sbeg, S. D. Uecged cdd deae: a a cae f d

    ac ea f e . Cde, LD, Ha, WH, Rae, PL,

    ad MacEe, GD. Pceedg f e d e cefc eeg f

    e ce , 212228. 1975. S.L, C.V.Mb.

    4  Cea DR, Waee R, Sbeg SD. Aceaba daa e

    ad. C O Rea Re 1983;175:7985.

    5  Haegaa Y, Iaa H, M M, Geda E, Sa S, Ma T: Te aa

    ce f ea f e de ba aceaba d

    aa. Ac O Taa Sg 1992;111:187191.

    6  M SB, Ga R, Me ME: Te g eaed daa f

    e . A d f adgac fac a edc e ce. J BeJ Sg A 1995;77:985989.

    7  Ma RO. Te aeg f a ea f e . B J Rad

    1965;38:81024.

    8  S L. Pae f ea f e . J Be J Sg B

    1976;58:17683.

    9  S L, Sce CM, Be JP. Oea f e : e a

    e bed e deae. A Re D 1982;41:11825.

    10 

    S L. Gegaca ad aaca ae f ea. B JRea 1984;23:17780.

    11  Ha WH. Pa ea f e : a ag dag. J

    Rea 1983;S 9:64.

    12  Ha WH. Eg f ea f e . C O Rea Re

    1986;(213):2033.

    13  Ga R, Pa J, Bec M, Leg M, N H, Sebec KA.

    Feaceaba gee: a cae f ea f e .

    C O Rea Re 2003;(417):11220.

    14  Ga R, Leg M, LegGa K, Ha WH. Te eg f

    ea f e : a egaed ecaca cce. C O

    Rea Re 2008;466:26472.

    15  Ga R, Kae K, V TS, Ma JW. A e eaceaba e f

    e eae f daa. Tece ad ea e. C

    O Rea Re 1988;232:2636.

    16  P RP, Kae K, Ga R, Ceae S. Aceaba ag ec

    da cgea daa e ad. A adgac d. C

    Oga M. 1995;80:361368.

    17 

    Ga R, G TJ, Gae E, Ga K, Kge N, Beea U. Sgca dca f e ad a ece f acce e fea ead

    ad aceab e f aaca ec. J Be J Sg

    B 2001;83:111924.

    18  I K, Ma MA 2d, Leg M, Wee S, Ga R. Feaceaba

    gee ad e caeffec. A MRIbaed aae aaca

    d f e fea eadec ffe. J Be J Sg B 2001;83:171

    6.

    19  I K, Leg M, Ga R. Hagc feae f e aceaba a

    b feaceaba gee. C O Rea Re

    2004;(429):26271.

    20  Kaaa A, Y LS, Bee E, C SA, M MB, Pae WE. Tad

    f MR agac fdg ae cae feaceab

    a gee. Radg 2005;236:58892.

    21  Jge M, Wd A, Weff B, Kae R. Feaceaba ge

    e caed b a fea e eadec b def: cca,

    adgca, ad eeea e. J O Sc 2004;9:25663.

    22  Bec M, Ka M, Leg M, Ga R. H g fece e

    ae f daage e aceaba caage: feaceaba gee a a cae f ea ea f e . J Be J Sg

    B 2005;87:10128.

    23  Sebec KA, Waab KH, Wee S, Ka M, L eg M, Ga R. Ab

    a ee f e fea ead e a a cae f ca

    gee. C O Rea Re 2004;(418):5460.

    24  Wage S, Hfee W, Ce M, MaVae P, Saffe E, Ga R,

    Sebec KA. Ea eac cage f a fea ead ca

    age bee feaceaba gee. Oea

    Caage 2003;11:50818.

    25  Taa M, Gc D, Bec M, M SB, Sebec KA. H daage

    cc a e e f feaceaba gee. C O Rea

    Re 2008;466:27380.

    26  Leg M, Bec M, Ka M, K YJ, Wee S, Ga R. Fbcc

    cage a aee fea ec: eaece

    feaceaba gee. Radg 2005;236:23746.

    27  Leg M, Bec M, W A, Da C, Keb M, Ga R. Aceaba

    degeea: a ca fdg e aged . C O Rea Re

    2003;(413):2017.28  Pfa CW, Megad B, Da C, Kabee F, Zae M, Hde J. Ca

    ad ce feaceaba gee: caacec MR a

    gac fdg 50 ae. Radg 2006;240:77885.

    29  Ha WH. Te cea beee ecged dee

    ea defe ad e deee f ea f e .

    I Ce L ec 2009;58:2579.

    30  Naaa S, Yaa J, Oa K, Taea K, Haaaa A, Maa

    T. Eaa f aceaba daa g a e f e

    eedea CT. J O Sc. 2000;5:533539.

    31  Ada S, Teee T, Kad KA, Sege S. Aceaba age ad

    fea aee dac ad: CT ega. J C

    A Tg. 1991;15:115120.

    32  Nbe P, Kaac E, Sga N, Mabaa M, Haada Y, O K,

    Paac V. Teedea ae f e dac fe: Ica

    f THR. C O Rea Re. 2003;417:2740.

    33  Jacbe S, Re L, Sbae K. Te e aea daa.

    C O Rea Re. 2006;446:239246.

    34  Jacbe S, Re L, Sbae K. Degeea dac . A ce ga d. Seea Rad. 2005;7:17.

  • 8/18/2019 Assessment of Adult Hip Dysplasia and the Outcome of Surgical Treatment

    15/17

      DANISH MEDICAL BULLETIN  15

    35  Kae K, D CW, Ga R. Te aceaba de. A cca

    eea f daa f e . J Be J Sg B. 1991;73:423

    429.

    36  Bd JW, Je KS. H ac e eece f daa. A

    c 2003;19:105560.

    37  Jacbe S. Ad daa ad ea. Sde adg

    ad cca edeg. Aca O. 2006;77(S 324):137.38  Macc B, Pe B, Ac V, Dae M, Igc A, KaIgc V. Maea

    ca ea f e db a ad dac a

    . J O Re. 2002;20:102530.

    39  Re ME, Saa KH, Gad NM, Pedee DR. Caage cac

    ee eea dac : a cc ead de. J O

    Sg. 2006;1:6.

    40  Macc B, Igc A, KaIgc V, Bad RA, Veg R. Cae c

    ac e edc ea DDH. C O Rea Re

    2008;466:88491.

    41  Ma JW, Be RL, Zebac J. Recgg aceaba e e

    adgac eea f daa. C O Rea Re

    2004;418:4853.

    42  Nee A, Tdae R, Ta Z, Maaf G, Pge J, Te N. De

    eea daa f e : aceaba ee a cca

    fac? O Taa Sg Re 2009;95:5119.

    43  G NJ, Tdae RT. Aceaba ee acaed

    ea f e . C O Rea Re 2003;417:2639.

    44 

    K WY, Hc CE, Ade JG, Ae PD. Te ea beeeaceaba ee ad ea f e . J Be J Sg

    B 2006;88:7279.

    45  Cf P, Ce C, Wca C, Cgg D. Oea f e ad

    aceaba daa. A Re D. 1991;50:308310.

    46  S RW, Egge P, Cgg D, Cae MI, Ce C. Oea f

    e ad aceaba daa e. A Re D.

    1995;54:179181.

    47  Jacbe S, SeH S. H daa: a gfca fac f e

    deee f ea. A ceca e. Rea

    g (Ofd). 2005;44:211218.

    48  Gda DA, Fega JE, S AD, Lae B, B RL, Cea DR.

    Sbcca ed caa fea e. Rea

    ea f e . J Be J Sg A 1997;79:14891497.

    49  Be RS, Dea Rcca GJ, Pae H, C M, Mae WJ, C JC.

    Cca eea f ae ea f e aceaba ab. J

    Be J Sg A 2006;88:144857.

    50  Fgead RH. Aceaba ab ea. Dag ad eae. C

    O Rea Re 1995;311:6068.51  Naa AA, Td E, Keda S, Cad R, Ta P. A ea

    e eaece f aceaba ab ea ae

    g a. Kee Sg S Taa Ac 2003;11:4038.

    52  Gg K, Jacbe S, SeH S, Pa H, Tee A. Peaece f

    afa f e ad e ea e, g Pa

    ad e f ea: a abaed e. J Be J

    Sg A 2010;92:11621169.

    53  Gg KK, Jacbe S, Pa H, SeH S, Mag E. A e a

    dgca de f aeg aec f e fea ead ca

    gee. J Be J Sg B 2007;89:13091316.

    54  Maeaa A, Na M, Maa S, Ya I. Peaceaba e

    edce e dac ab f dac . J Be J Sg

    B 2009;91:143842.

    55  N HP, W TF, Sec CH, Scd MR, Tebe K, Hde J. Te

    c f e fea eadec c a a edc f e f

    ae gee. J Be J Sg B 2002;84:55660.

    56  Wege DE, Kede KR, Me MR, Tdae RT. Aceaba aba ea

    ae cc e abece f b abae. C O Rea Re2004;426:145150.

    57  Peee MW, Dea Rcca GJ, Mae WJ, C MC, C JC. Aceab

    a ad fea adgac abae acaed aba ea.

    C O Rea Re 2005;441:32733.

    58  Geaa CJ, Peb R, Cae JT, O SA, Va TP. Ceee

    gc eaa f e ae ac aba

    ea. C O Rea Re 2006;453:27785.

    59  Jacbe S, SeH S, Sbae K, Geb P, Ld B. H daa

    ad ea: a e f 4151 bec f e Oea

    Sbd f e Ceage C Hea Sd. Aca O

    2005;76:149158.

    60  Rea M, Hae JM, P HA, Ke BW, BeaZea SM. Aceab

    a daa edc cde ea f e : e Reda

    d. A Re 2005;52:78793.

    61  Lae NE, L P, Cae L, Ge LR, Wa EN, Hcbeg MC,

    Ne MC. Aca f d aceaba daa a ceaed

    f cde ea ede e e: e d f

    ec face. A Re 2000;43:4004.

    62  Jee RH, Za D, Ze C, Be D, Ga ML, K YJ. Rad

    gac ad ae fac acaed eadgac

    ea daa. J Be J Sg A 2009;91:11209.

    63  Te Da H Reacee Rege. Te Da H Reacee Reg

    e. Deae f Oedc ge, Ue Ha f Aa,

    Dea. 2004;149.

    64 

    Ece TM, Taa M, P M, Se bec KA, M SB. Pagc aea edc eece abece f ea.

    C O Rea Re 2007;465:4652.

    65  Ba HJ, Caa GL, Beab AC, Rdge MB, Lee LE. Fea

    eadec c def eaed ea f e . C

    O Rea Re 2010;468:19205.

    66  Tae M, Ne N. Oe abae ad ea ea:

    e e f gee. C O Rea Re 2004;429:1707.

    67  C JC, Sc AL, S J L, Sceece PL, Wg RW. Pe

    aceaba e: a eac eae ee. C O Rea

    Re 2009;467:204152.

    68  T D. Cgea Daa ad Dca f e H Cde

    ad Ad. Be, Hedebeg, Ne Y: Sge; 1987.

    69  Sa I. Aceaba daa. J Be J Sg B. 1961;43:268272.

    70  Hea CH, Hed CH. LeggPee Deae. A ed f e

    eaee f e egegac e. J Be J Sg A.

    1950;32:767778.

    71  Gda SB. Ca f adgac aaee f aa f

    a ad dac e ad. Ce O 1990;20:505511.

    72  Ka M, Macc B, Ac V, Igc A, KaIgc V. Te Beee e

    aceaba e: cca, adgac ad ecaca 715ea

    f f 26 . Aca O 2005;76:833840.

    73  Seace SD, Taa M, Ga R, Sebec KA. Mea 20ea f

    f Beee eaceaba e. C O Rea Re

    2008;466:16331644.

    74  Maee T, K YJ, Za D, Mae C, M M. Ieedae

    ge e fg e Beee eaceaba e ad

    edc f cca ce. J Be J Sg A 2009;91:211323.

    75  Tee A, Eegaad B, Re L, Sbae K. Reabe Age Ae

    e Dg Peaceaba Oe a Ne Dece. C O

    Rea Re 2008;466:11691176.

    76  C JC, Cae JC, Tdae R, K YJ, Beae PE, Mga P, Sege

    Ma K, Sceece PL, M M. Radgac eaa f e a

    ed eab. C O Rea Re 2009;467:66675.

    77  Ne M, Gee KP, Ge S, P W. Reab f adgca

    eaee e aee f daa ad. B J Rad1999;72:3314.

    78  Oeg H, Bg A, Agş H, Te Y. Meaee f cee

    edge age deeea daa f e : a ca f

    ed ae de 20 ea f age. Seea Rad 2002;31:25

    9.

    79  Pa NM, Ma DW, Ba TP, Be MK. E eae

    e f aceaba de. J Peda O 1995;15:7804.

    80  Ba F, Keda K. Sce f e e ege eaa f e

    fac. A Rad 1968;11:298303.

    81  Jacbe S, SeH S, Ld B, Sbae K, K T, Rg H, Mad

    H. Pec ea ad aee f daa ad. Aca O

    2004;75:721729.

    82  Sebec K, Kabeae D, Ga R. Effec f ec aceaba

    ee: a d f ee f cadae. C O Rea Re

    2003;407:2418.

    83  Ee M, Na M, Ie T. Te eaece f aceaba ee

    ag a dde f e . J Be J Sg A 2006;88:372

    9.84  Kaa T, Na M, Sa K, Sda T. Peae aceaba

    ee cae e ea f e . I O

    2009;33:62531.

    85  Xe J, Na M, Maeaa A. Eaa f aceaba e afe a

    ced eaceaba e f dac . I O

    2010;34:4737.

    86  F M, Naaa Y, Yaa T, Maaa T, Ma G, Ma

    a A, Mada S, Jg S, Ia Y. Aceaba ee

    deeea daa f e . J Be J Sg A 2010;92:895

    903.

    87  Ada S, Sege S, Ged T, Be P. Pec ca ad

    aa ea f e aceab. A adgac, ced

    gac ad cca ega. Aca Rad 1990;31:38994.

    88  K N, Me N, Me T. Deea f aceaba ceage f

    e fea ead e f a ge aee adga. A e

    ceed ece. J Be J Sg A 1993;75:13181333.

    89  Edde TA, Mgad H, Cae C, Ce A, Fae C, De A.

    Vaa f ec aee e g ad adg :aa f 24 c bec ad ca f CT eaee f

    f a ec c. Sg Rad Aa 2001;23:10510.

  • 8/18/2019 Assessment of Adult Hip Dysplasia and the Outcome of Surgical Treatment

    16/17

      DANISH MEDICAL BULLETIN  16

    90  Naa S, Sga N, N T, O K, Yaa H. Meaee

    f ec fe age g eedea ced ga.

    C O Rea Re 2003;411:140151.

    91  Lebec B, Mee O, Ree P, Wee N. Pec ae aceaba

    c aga accae. Aca O 2005;76:51723.

    92  Ma E, Kee O, Pa A, Racbae F, Ke M, Nge M. Te

    fa ec ae de a ad efeece e f aaf e aceaba c: aa ea f e e dffee

    . Aca O 2005;76:84853.

    93  Babc JW, Lae F, A LP. Te aae f aded aceab

    a c aga. J Be J Sg A 2008;90:35765.

    94  FcWea S, Peee C D, Tbe CO, Wee SL. Ca

    f ec adga egbeag ad e . C O

    Rea Re 2008;466:80912.

    95  Aa RD, Bc DA, Dgad M, Hcbeg M, Lade S, Paea

    K, Sec T, Vg E. Meaee f ca ge

    ea f e : e Bacea ce g. Oea

    Caage 2004;12:515524.

    96  Ce T, Leee MG, T AM, Mae P, Beda L, Vg E.

    Te effec f e adgac ace ea

    f e . Oea Caage 1997;5:1722.

    97  Taa M, M S, Lag F, Ade S, Sebec K. Ea

    f ec aee aa ca f aaee.

    Seea Rad 2006;35:14955.

    98 

    Red D, Lca J, Kae K . Ree f e aceab. A cae f a. J Be J Sg B 1999;81:281288.

    99  Jaa AA, Made K, Mee DC, Mae A, Bec M, Ga R, Leg

    M. Ae ec adga ae aceaba ee: g

    ad f e ceg. J O Re 2007;25:758765.

    100  Ada S, Teee T, Kad KA. Ced ga eaee

    f e aceab ad dac : c ee aae?

    Seea Rad 1991;20:26771.

    101  L PL, Ga R. Mgc feae f cgea aceaba daa:

    e eeed. C O Rea Re 2003;416:24553.

    102  Pee CL, Ec JA, He JL. Ea e f e Beee e

    aceaba e: e eag ce a a acadec edca ce

    e. J Be J Sg A 2006;88:19201926.

    103  Kabee F, Sea RJ, Mada SS, Ga R, Leg M. Ica e ec

    e e : a e g f aceaba ee. C O

    Rea Re 2008;466:67783.

    104  Kae T, Kca T, Neebg C, Lace S, Bege R , Rece H. Re

    ab f adgac g f aceaba ee. I O 2010

    Ma 10. [Eb aead f ]105  Bad JM, Aa DG. Saca ed f aeg ageee be

    ee ed f cca eaee. Lace 1986;1:307310.

    106  Bad JM, Aa DG. Ag e g ac: aae f ea

    ee de. Uad Obe Gec 2003;22:8593.

    107  Feg SJ, Ba JT, Ga R, I K. Te fece f e aceaba a

    b ca age cda: a eac fe eee

    de. J Bec 2000;33:95360.

    108  Feg SJ, Ba JT, Ga R, I K. A ega f

    aceaba aba ea ecac. J Bec 2003;36:1718.

    109  McCa JC, Nbe PC, Scc MR, Wg J, Lee J. Te e f aba e

    deee f ea degeeae deae. C O Re

    a Re 2001;393:2537.

    110  McCa JC, Nbe PC, Scc MR, Wg J, Lee J. Te aeed aba

    e: ea ea a f e . J Aa

    2001;16 S.1:817.

    111  De JH, Caea A. Te aceaba ab. J Be J Sg B

    1986;68:4003.

    112  Cafd MJ, D CJ, Aeade JW, T M, Scde SJ, Vega CE,Pae RV, Me AR, McCa JC, Le WR, Nbe PC. Te 2007 Fa

    Scfed Aad. Te becac f e ab ad e ab

    f e . C O Rea Re 2007;465:1622.

    113  McCa JC, Lee JA: Aceaba daa: a aadg f acc

    eaa f cda e. C O Rea Re 2002;405:122

    128.

    114  Maeaa A, Na M, Maa S, Ya I. Eaa f dac

    ab f e dac e f aa acceee. J Be

    J Sg A 2008;90:8592.

    115  Leg M, Pdea D, Bec M, Wee S, Ga R. Magec eace

    aga f aba dde daa ad ge

    e. C O Rea Re 2004;418:7480.

    116  Ca M, Uff H, O'Ne M, Bea PE. Ebg f e aceab

    a abacda ce. J Be J Sg B 2008;90:101924.

    117  Taa GA, Ha WR, Ma NM, Kc SM, Va TP. Se

    f MR aga e eaa f aceaba aba ea. A J

    Rege 2006;186:44953.

    118  Ca YS, Le LC, H HL, Wa YL, Lee MS, H KY e a. Eaag aba ea g agec eace aga: a ece d

    cag ac ad agec eace aga dag

    . Ac 2005;21:1250.

    119  Feeda BA, Pe BK, Dae PA, Ga JR, K TR, M KP.

    Pgc ae f agec eace aga f Ce age II

    ad III aceaba aba ea. Ac 2006;22:7427.

    120  Zege AJ, Baebae DG, De Se AA, Keee JS, S K, Fe JP.

    Ca f adad MR agac agg ae ad eece f deec f acca e aba ea. AJR A J

    Rege 2009;192:1397400.

    121  Ce C, Hfa S, Ned A, Tcae C, Ege A, Rec MP e a.

    Le f e aceaba ab: accac f MR agg ad MR a

    ga deec ad agg. Radg 1996;200:22530.

    122  Ce C, Hfa S, Uba M, Tcae C, Ned A, Peeebe

    M e a. MR aga f e ad aceaba caaaba c

    e: cea ge ad aa. A J Rege

    1999;173:3459.

    123  Keee JA, Peee MW, Jac J, Rb D, Mae WJ, C JC.

    Magec eace aga e ac e eaa

    f aca ag. C O Rea Re 2004;429:1639.

    124  Leg M, Wee S, Ugebc A, I K, Ga R. Eaa f e

    aceaba ab b MR aga. J Be J Sg B

    1997;79:2304.

    125  Mce B, McC P, Be P, O'De J, C E, He R. H

      ag: cca eea ad cea beee agec

    eace aga, ad, ad acc fdg 25cece cae. C J S Med 2003;13:1526.

    126  Sfa CM, Ade RS, Da MA. Sga f e aceaba ab:

    aa f aba e dg aaca ec. J Ua

    d Med 2006;25:132126.

    127  Ma RL, Ke BT, Leg M, Ma HD, Mad NG, P MJ,

    Sea JK, Safa MR. Reab f c ca dag aaca

    deae. Kee Sg S Taa A c 2010;18:68590.

    128  Ma RL, Sea JK. Te eae eab f 4 cca e ed

    ae dda ceea a. J O S P

    Te 2008;38:717.

    129  C JC, Bea PE, O'Mae A, Safa MR, Sceece P. AOA

    . H deae e g ad: ce cce f eg ad

    gca eae. J Be J Sg A 2008;90:226781.

    130  Tee A, Re L, Sbae K. H daa: cca aee, a

    dgc eaa ad efeece. Uge Laege 2007;169:3946.

    131  Sebec KA, Sc E, Lebac M, Ga R. Beee eaceaba

    e. C O Rea Re 1999;363:920.

    132  Tdae RT, Eea A, Ga R, Wac SL. Peaceaba adecaec e f e eae f ea d

    ac . J Be J Sg A 1995;77:7385.

    133  Tbe SJ, Ma KA, Ma JW. Te eaceaba e. M

    2 ea f e a 100 . C O Rea Re

    1999;363:5463.

    134  M SB, M MB. Peaceaba e abdc d

    ec g dec ae ee. C O Rea Re

    1999;364:9298.

    135  C J, Bae S, Gd J, Degad E, Sceece P. Peaceaba

    e f e eae f eee aceaba daa. J Be

    J Sg A 2005;87:254259.

    136  Ccae J J, Tdae RT, Cabaea ME e a. Ea eeece ad e

    e eaceaba e. Te Ma Cc eeece.

    C O Rea Re 1999;363:4553.

    137  Maa JM, Se MD, Sebec K. Peaceaba e g

    e SPeee aac. C O Rea Re 1999;363:2132.

    138  Pgac F, Sa A, Waee R. Peaceaba e. Gd

    a eef ac daa, 32 ae fed f 4ea. Aca O Scad 2005;76:6774.

    139  Gaa DN, Cde TT, O SA. Mede e f e Beee

    eaceaba e e eae f ac dee

    ea daa f e . J Be J Sg B 2007;89:721724.

    140  Tee A, Eegaad B, Sbae K. A e a ae aa

    a aac f eaceaba e. J Be J S g A

    2008;90:493498.

    141  Tee A, Eegaad B, Sbae K. Ca f e a a

    e ad ga aace f eaceaba e: 263

    gege cede edefed d g. Aca O

    2008;79:77784.

    142  M MB, Ka M, Sea R, Tdae R, Ta MJ, K YJ, Refed

    SB, Kaa G, Sceece P, C JC. Peaceaba e f

    aceaba daa ae de a 40 ea: a ea d.

    C O Rea Re 2009;467:222834.

    143  Cga T, Jee R, Za D e a. Deaed gad

    eaced agec eace agg f caage edc ea fa

    e f Beee eaceaba e f daa. J Be JSg A 2006;88:15408.

  • 8/18/2019 Assessment of Adult Hip Dysplasia and the Outcome of Surgical Treatment

    17/17

      DANISH MEDICAL BULLETIN  17

    144  Bedea R, Da L, Gabe A, Wace R, K e M, Bee H.

    Cca ad ae afac afe eaceaba e.

    I O. 2007 [Eb aead f ]. DOI 10.1007/002640070372

    3

    145  a Bega AB, Gab DS. Qa f fe ad ecfc ce

    afe Beee eaceaba e. J Be J Sg B

    2002;84:33943.146  Tee A. Sgca adace eaceaba e f ea

    e f daa ad. Aca O S 2009;80(332):133.

    147  Sbae K. Pec e f aceaba daa. Aca O Scad

    2003;74:117118.

    148  Mecebg I, Negaad J, Re L, Sbae K. Cage ad

    beag aea afe Ga eaceaba e eaaed b

    ce CT cag ad eeg. Aca O Scad 2004;75:147153.

    149  H JA, Sga N, M NB, M SB. Pag aceaba edec

    ee baed cac ee. C O Rea

    Re 1999;364:134143.

    150  Tdae RT, Cabaea ME. Le eaed afe e a 250 e

    aceaba ee. Aca O Scad 2003;74:119126.

    151  Be JB, Dagaad MT, Wa T, Bec P, Rae NK, Kee

    TS, Mdg J, Tedbg K. Da aa f SF36. Ceage: Lf;

    1997.

    152  Bea N. WOMAC ea de. Ue gde VIII. WOMAC a

    egeed adea Caada f Nca Bea.

    153 

    Pedee A, Je S, Oegaad S, Sbae K, See HT, Lc U.Rega e Da aa eg: ceee f

    a aae ad e edce ae f egeed dag

    ad eae cca. Aca O Scad 2004;75:434

    441.

    154  M S, De R. Peaceaba e: eeae ad

    gac edc f ce. C O Rea Re 2002;405:168174.

    155  Saf E, Saf H, Med S e a. Ceffecee aa f e

    aceaba e. J Be J Sg A 2008;90:14471456.

    156  N HP, Me SM, Ga R. Te ea beee fea ca

    fe ad eg beag aea e a ad dac

    ad: a adgc d. Z O 2001;139:502506.

    157  Oa K, E H, Oa M, Sd H. Oce f aa

    aceaba e f ea ea ecda daa

    eaed fea ead ae. 49 fed f 1017 ea. Aca

    Oaedca 2008;79:1217.

    158  Pa J, Bca O, Bede B, Maa SM, P JJ, Ec J, Pee C.

    Ac f aba ea ae deeea daa f

    e : a caa e. J Aa 2009;24(6 S):1103.159  Mecebg I, Negaad JR, Geec J, Sbae K. Caage ce

    e eaed b MRI ad eega edgca

    d. Oea Caage 2007;15:36671.